Neurocrine Biosciences (NBIX) Tops Q3 EPS by 75c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $160.47 +1.38%
Revenue Growth %: +26.4%
Financial Fact:
Net income (loss): -36.89M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +26.4%
Financial Fact:
Net income (loss): -36.89M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of $0.97, $0.75 better than the analyst estimate of $0.22. Revenue for the quarter came in at $258.5 million versus the consensus estimate of $283.04 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- AeroVironment restates quarterly financials, citing $89M goodwill error
- Dutch Bros Inc. (BROS) PT Raised to $90 at DA Davidson on Sales/Earnings Upside
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
